BMO Capital Downgrades Gilead Sciences (GILD) to Market Perform; Risk/Reward Unfavorable
Tweet Send to a Friend
(Updated - April 20, 2020 4:46 AM EDT)(updating comment)BMO Capital analyst Matthew Luchini downgraded Gilead Sciences (NASDAQ: GILD) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
